4//SEC Filing
Dicerna Pharmaceuticals Inc 4
Accession 0000899243-16-022938
CIK 0001399529operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:16 PM ET
Size
10.4 KB
Accession
0000899243-16-022938
Insider Transaction Report
Form 4
MADDEN DAVID
Director
Transactions
- Award
Director Stock Option (right to buy)
2016-06-14+20,000→ 20,000 totalExercise: $3.26Exp: 2026-06-14→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The option vests in full on June 14, 2017 subject to the Reporting Person's continued service to the Issuer through such date.
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001399529
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 4:16 PM ET
- Size
- 10.4 KB